A Phase 3 interventional study of Capnography and Standard monitoring in In the Study the Value of Capnography for Avoiding Complications During Sedation for PEG is Evaluated., sponsored by Ruhr University of Bochum. Status unknown at 3 sites in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-11-22.
Sponsored by Ruhr University of Bochum · Phase 3, Interventional, and Prevention
In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.
Ruhr University of Bochum is the lead sponsor of 124 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Arm with capnographic monitoring
Device: Capnography
Standard monitoring
Device: Standard monitoring
Capnographic monitoring
Standard monitoring
Hypoxemia
Time frame: From the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h
Further complications
Time frame: From the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h
This study is status unknown, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ruhr University of Bochum